These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 3895734)
1. [Micromodification of the leukocyte adherence inhibition test for cancer patients]. Kharkevich DD; Tabagari DZ; Savinov AIu Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734 [TBL] [Abstract][Full Text] [Related]
2. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer]. Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405 [TBL] [Abstract][Full Text] [Related]
3. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer. Tsang PH; Holland JF; Bekesi JG J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442 [TBL] [Abstract][Full Text] [Related]
4. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays. Shenouda G; Thomson DM; MacFarlane JK Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056 [TBL] [Abstract][Full Text] [Related]
5. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay. Shenouda G; Thomson DM Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766 [TBL] [Abstract][Full Text] [Related]
6. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test]. Ludwig HJ; Storch H Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755 [TBL] [Abstract][Full Text] [Related]
7. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique. Kotlar HK; Sanner T J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay. Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173 [TBL] [Abstract][Full Text] [Related]
9. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes. Grosser N; Thomson DM Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110 [TBL] [Abstract][Full Text] [Related]
10. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer. Halliday WJ; Koppi TA; Khan JM; Davis NC J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045 [TBL] [Abstract][Full Text] [Related]
11. [Changes in sensitivity of lymphocyte cholinergic receptors in patients with breast cancer]. Kharkevich DD; Polevaia EB Eksp Onkol; 1988; 10(5):38-40. PubMed ID: 2905257 [TBL] [Abstract][Full Text] [Related]
12. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test]. Okada Y Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679 [TBL] [Abstract][Full Text] [Related]
13. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients. Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799 [TBL] [Abstract][Full Text] [Related]
14. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses]. Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the mechanism of the leukocyte adherence inhibition test. Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586 [TBL] [Abstract][Full Text] [Related]
16. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer. Horváth M; Tóth L; Tóth J; Fekete B Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415 [TBL] [Abstract][Full Text] [Related]
17. [Leukocyte adherence inhibition test (LAI): instrumentation, procedure and possibilities for use]. Lehmitz R; Grap H; Schulze H; Ziegler K Z Med Lab Diagn; 1982 Jan; 23(1):49-54. PubMed ID: 7046275 [No Abstract] [Full Text] [Related]
18. [Study of the participation of the alpha-chain of the LFA-1 antigen in the phenomenon of lymphocyte adherence inhibition using ICO-11 monoclonal antibodies in vitro]. Kharkevich DD; Baryshnikov AIu; Savel'eva EV; Polevaia EB; Kadagidze ZG Biull Eksp Biol Med; 1987 Dec; 104(12):711-3. PubMed ID: 3318954 [TBL] [Abstract][Full Text] [Related]
19. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer. De Carli HO; Restbergs V Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830 [TBL] [Abstract][Full Text] [Related]
20. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition]. Fritze D; Fritze J; Kaufmann M; Drings P Minerva Med; 1978 Nov; 69(58):3963-7. PubMed ID: 740287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]